New research from Memorial Sloan Kettering Cancer Center (MSK) led by medical oncologist Shari Goldfarb, MD, and colleagues, reports positive findings for the use of Addyi (flibanserin) tablets in breast cancer patients on endocrine therapy who are suffering from treatment- or disease- induced low libido. There are currently a lack of effective treatment options for…
eTurboNews izindatshana ezababhalisi kuphela. Ukubhalisa kuyinto MAHHALA.
Ababhalisile bangena lapha Chofoza lapha ukuze ubhalise MAHHALA
Ababhalisile bangena lapha Chofoza lapha ukuze ubhalise MAHHALA
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- New research from Memorial Sloan Kettering Cancer Center (MSK) led by medical oncologist Shari Goldfarb, MD, and colleagues, reports positive findings for the use of Addyi (flibanserin) tablets in breast cancer patients on endocrine therapy who are suffering from treatment- or disease- induced low libido.
- There are currently a lack of effective treatment options for….
- eTurboNews izindatshana ezababhalisi kuphela.
